The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Grimm Donald W since 2007.
The trader's CIK number is 1208809.
At the time of the last reporting, Grimm Donald W was the Director of Invitrogen Corp. (stock ticker symbol IVGN).
Also see all insider trading activities at Invitrogen Corp.
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2012 | LIFE | 0 | $0 | 12,052 | $577,752 | 0 | $0 |
2011 | LIFE | 0 | $0 | 0 | $0 | 4,052 | $150,774 |
2010 | LIFE | 0 | $0 | 20,000 | $929,920 | 20,000 | $666,200 |
2009 | LIFE | 0 | $0 | 20,000 | $933,259 | 20,000 | $578,800 |
2007 | LIFE | 0 | $0 | 27,100 | $2,357,948 | 31,900 | $1,634,197 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2012-11-19 | LIFE | Sale | 4,052 | 47.86 | 193,912 |
2012-11-20 | LIFE | Sale | 8,000 | 47.98 | 383,840 |
2011-10-03 | LIFE | Option Ex | 4,052 | 37.21 | 150,774 |
2010-09-09 | LIFE | Option Ex | 20,000 | 33.31 | 666,200 |
2010-09-09 | LIFE | Sale | 20,000 | 46.50 | 929,920 |
2009-09-09 | LIFE | Option Ex | 20,000 | 28.94 | 578,800 |
2009-09-09 | LIFE | Sale | 20,000 | 46.66 | 933,259 |
2007-11-07 | IVGN | Sale | 4,500 | 91.01 | 409,563 |
2007-11-07 | IVGN | Option Ex | 20,500 | 67.65 | 1,386,825 |
2007-11-07 | IVGN | Sale | 4,000 | 91.02 | 364,088 |
2007-11-07 | IVGN | Option Ex | 200 | 91.02 | 18,204 |
2007-11-07 | IVGN | Sale | 2,700 | 91.02 | 245,748 |
2007-11-07 | IVGN | Option Ex | 300 | 91.02 | 27,304 |
2007-11-07 | IVGN | Sale | 5,121 | 90.99 | 465,949 |
2007-11-07 | IVGN | Option Ex | 900 | 90.96 | 81,864 |
2007-11-07 | IVGN | Sale | 1,779 | 90.84 | 161,600 |
2005-05-18 | IVGN | Sale | 9,000 | 79.00 | 711,000 |
2005-05-18 | IVGN | Option Ex | 10,000 | 12.00 | 120,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Grimm Donald W (Director of Invitrogen Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.